Strains used in this study. by Xin Zhou (54275)

Primers used in this study. by Xin Zhou (54275)

<i>ERG251</i> SNPs from all FLC-evolved strains. by Xin Zhou (54275)

Results of comparison between Model5 and Model9. by Taiga Mori (21410076)

Results of comparison between Model5 and Model10. by Taiga Mori (21410076)

Erg251 is the major methyl sterol oxidase controlling drug susceptibility compared to its paralog Erg25. by Xin Zhou (54275)

Small Open Reading Frames, Non-Coding RNAs and Repetitive Elements in <i>Bradyrhizobium japonicum</i> USDA 110 - Fig 3 by Julia Hahn (3279486)

Subjects:

Procedures of sampling and measurements. by Xuegang Mao (599968)

Subjects:

Introduction status of PCVs in European countries over time. by Heloisa Ricci Conesa (18291210)

Subjects:

Estimates for direct medical and total costs per AOM episode (2020 EUR), by country [35, 96–100]. by Heloisa Ricci Conesa (18291210)

Subjects:

Vertical distributions in the three field settings. by Xuegang Mao (599968)

Subjects:

Fig 5 - by Kellie J. Walters (10451329)

Subjects:

<i>prx-5/6</i> mutations likely cause a decrease in mmBCFA degradation. by Rencheng Wang (463927)

“…<i>elo-5</i>(<i>lf</i>)<i>; Ex</i>[<i>elo-6</i>] is a transgenic strain that significantly overexpressed the <i>elo-6</i> gene and was not sufficient to suppress the L1 arrest phenotype of <i>elo-5</i>(<i>lf</i>). …”

HAstV-1 infection leads to a decrease in epithelial markers while increasing mesenchymal markers. by Virginia Hargest (12447014)

Heterocene Catalysts and Reaction Temperature Gradient in Dec-1-ene Oligomerization for the Production of Low Viscosity PAO Base Stocks by Ilya E. Nifant’ev (1561813)

Subjects:

CYP3A94 activity is significantly increased in V79-CYP3A94/DD-POR cells, but decreases after incubation with Shield-1. by Ramona Dettwiler (664360)

Gut richness and diversity decrease significantly by week 5 of chemoradiotherapy. by Molly B. El Alam (10231830)

Supplementary Material for: Adjunctive active vitamin D (AVD) decreases kidney function during treatment of secondary hyperparathyroidism (SHPT) with extended-release calcifediol (... by figshare admin karger (2628495)

Representative fluorescent records of IntegriSense 680^® dye-labeled αvβ3 integrin in control and cetrorelix-treated non-pregnant rats. by Kalman F. Szucs (19353218)

“…Cetrorelix treatment reduced αvβ3 integrin expression, which caused a significant decrease in intensity (bottom image row). …”

Distribution of miRs with a greater than two fold-change. by Stephanie L. Samani (17896610)

Subjects: